Research location
Le Chesnay
France
Advertisement
Research activity in Le Chesnay
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 81 trials and 84 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Le Chesnay
81 linked trials · page 1 of 2A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 1 site observation
RECRUITING
Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria.NCT07315347 · 2026-02-02 · 1 site observation
RECRUITING
Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported OutcomesNCT07380711 · 2026-01-28 · 1 site observation
RECRUITING
Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant RibociclibNCT07237256 · 2025-12-18 · 1 site observation
RECRUITING
Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung CancerNCT07563205 · 2025-11-19 · 1 site observation
RECRUITING
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaNCT07219173 · 2025-10-22 · 1 site observation
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation
RECRUITING
PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic MalignanciesNCT06646471 · 2024-09-26 · 1 site observation
RECRUITING
COPD-ICU Multicentre Prospective Observational RegisterNCT05734365 · 2022-11-01 · 1 site observation
RECRUITING
Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.NCT06257329 · 2022-10-01 · 1 site observation
RECRUITING
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy InductionNCT05255302 · 2022-05-02 · 1 site observation
RECRUITING
Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLCNCT05122806 · 2021-09-22 · 1 site observation
RECRUITING
French Registry for Monitoring Pregnancies for Multiple SclerosisNCT03900221 · 2019-08-12 · 1 site observation
RECRUITING
Posterior Reversible Encephalopathy Syndrome in the Critically Ill PatientsNCT03470467 · 2018-03-09 · 1 site observation
RECRUITING
Cohort IMEA 070 -Lenacapavir CompassionalNCT06289361 · 2024-04-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or RibociclibNCT05625087 · 2023-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & ChemotherapyNCT05781308 · 2023-04-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigmaNCT05149001 · 2022-01-17 · 1 site observation
COMPLETED
Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.NCT04640935 · 2019-10-01 · 1 site observation
COMPLETED
A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic SettingNCT03589105 · 2018-08-06 · 1 site observation
COMPLETED
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)NCT03521934 · 2018-06-15 · 1 site observation
TERMINATED
Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC PatientsNCT03351361 · 2018-02-19 · 1 site observation
COMPLETED
ANRS CO24 OncoVIHAC (Onco VIH Anti Checkpoint)NCT03354936 · 2018-01-17 · 2 site observations
UNKNOWN
Exploration of Microcirculatory Alteration and Endothelial Dysfunction by Adaptive Optics in Multiple SclerosisNCT03508089 · 2017-08-22 · 1 site observation
UNKNOWN
Explorations of the Normal Neural Behavioral and Pathological Bases of MetacognitionNCT03140475 · 2017-04-27 · 1 site observation
COMPLETED
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation DetectionNCT03079011 · 2017-03-22 · 1 site observation
COMPLETED
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionNCT02929329 · 2017-01-06 · 1 site observation
COMPLETED
Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU ProgramNCT02933346 · 2016-09-01 · 1 site observation
COMPLETED
Animated Cartoons and Cooperation in Young Children Receiving Inhaled MedicationsNCT02879240 · 2016-08-01 · 1 site observation
COMPLETED
Impact of Emotional Skills of Young Women and Their Partner on Adjustment to CancerNCT02861742 · 2016-07-25 · 1 site observation
COMPLETED
Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin TreatmentNCT02967237 · 2016-01-04 · 1 site observation
COMPLETED
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.NCT02437318 · 2015-07-23 · 1 site observation
COMPLETED
Screening Strategy for Asymptomatic Sexually Transmitted Infections (STI) in a Cohort of HIV Outpatients Men Who Have Sex With Men (DRIVER)NCT02413632 · 2015-04-01 · 1 site observation
COMPLETED
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLCNCT02273375 · 2015-02-24 · 1 site observation
COMPLETED
Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of LungNCT02853188 · 2014-12-04 · 1 site observation
COMPLETED
Optimizing the Care Pathways of Patients Treated for Operable Breast.NCT02813317 · 2014-12-01 · 1 site observation
COMPLETED
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase InhibitorsNCT02228382 · 2014-11-07 · 1 site observation
TERMINATED
Analysis of Immune Response In Bacterial Infection of Obese SubjectNCT02882568 · 2014-08-01 · 1 site observation
COMPLETED
A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaNCT02130557 · 2014-07-15 · 1 site observation
COMPLETED
Heart Failure Educational and Follow up PlatformNCT02110433 · 2013-12-01 · 1 site observation
COMPLETED
Multicentre Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral RegurgitationNCT01920698 · 2013-11-01 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHFNCT01870778 · 2013-10-02 · 2 site observations
COMPLETED
Efficacy Study of Herceptin to Treat HER2-negative CTC Breast CancerNCT01548677 · 2013-04-01 · 1 site observation
COMPLETED
Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients FunctioningNCT02901015 · 2013-04-01 · 1 site observation
COMPLETED
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast CancerNCT01698918 · 2013-03-07 · 1 site observation
COMPLETED
Normal and Abnormal ERP During ToM and Emotional Conflicts in SchizophreniaNCT02896374 · 2013-03-01 · 1 site observation
COMPLETED
A Study for Tyrosine Kinase Inhibitors DiscontinuationNCT02897245 · 2012-12-01 · 1 site observation
UNKNOWN
French Biological Observatory on Lung Cancer in Never SmokersNCT01465854 · 2011-11-01 · 1 site observation
COMPLETED
Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)NCT01357655 · 2011-09-01 · 1 site observation
TERMINATED
Psychometric Validation (Quality-of-life Scale) in Young Women With a Non Metastatic Breast Cancer and Her PartnerNCT02858063 · 2010-01-11 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.